• Exchange: Berlin
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma


Price not available for X8CN:GR

Snapshot for Endocan Corp (X8CN)

Open: - Day's Range: - Volume: 0
Previous Close: 0.001 52wk Range: - 1-Yr Rtn: -

Stock Chart for X8CN

No chart data available.
  • X8CN:GR
  • 1M
  • 1Y
Interactive X8CN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for X8CN

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. DAX -
Earnings Per Share (ttm) -
Est. EPS -
Est. PEG Ratio -
Market Cap (M EUR) 0.00
Shares Outstanding (M) 67.89
30 Day Average Volume -
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for X8CN

No data available

Company Profile & Key Executives for X8CN

Endocan Corporation produces cannabinoid-based health products. The Company focuses on developing cannabinoid formulations to help patients with multiple ailments, from minor skin care to life threatening diseases. Endocan serves the cosmetic, health and nutrition industries.

Dorothy BrayPresidentChad S JohnsonCOO/General Counsel
Robert J Kane "Bob"Senior VP:Business Dev/CFOWilliam S BottoVP:Exploration & Development
More Company Profile & Key Executives for X8CN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil